Semin intervent Radiol 2019; 36(03): 249-254
DOI: 10.1055/s-0039-1694698
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Percutaneous Interventional Management of Spinal Metastasis

Seon-Kyu Lee
1   Department of Radiology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York
,
Brandon Weiss
2   Department of Neurosurgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York
,
Vijay Yanamadala
2   Department of Neurosurgery, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York
,
Allan Brook
1   Department of Radiology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
19 August 2019 (online)

Preview

Abstract

Spinal metastasis is usually associated with debilitating pain and results in deteriorating life quality. The role of percutaneous management of spinal metastasis has evolved from a diagnostic role to a significant part of therapeutic options in conjunction with conventional management techniques, including radiotherapy and open surgical options. Percutaneous vertebral augmentation (PVA) showed substantial pain reduction, vertebral stabilization, and improvement of quality of life. Minimally invasive local ablative procedures (MILAPs) demonstrated significant pain reduction, local tumor burden control, and improvement of quality of life. Though combined PVA and MILAP's synergistic role in pain reduction may need additional investigation, considering different actions on spine metastasis patients, combining both techniques might beneficial to selected patients. The role of percutaneous management will likely expand since its role in improving patient's quality of life with very minimal procedure-related risk and in conjunction with future technological advancement.